Human TIM-3 PerCP-conjugated Antibody
Human TIM-3 PerCP-conjugated Antibody Summary
Ser22-Arg200
Accession # Q8TDQ0.2
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Detection of TIM‑3 in Human Blood Monocytes by Flow Cytometry. Human peripheral blood monocytes were stained with Rat Anti-Human TIM-3 PerCP-conjugated Monoclonal Antibody (Catalog # FAB2365C, filled histogram) or isotype control antibody (Catalog # IC006C, open histogram). View our protocol for Staining Membrane-associated Proteins.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, 2 to 8 °C as supplied.
Background: TIM-3
TIM-3 (T cell immunoglobulin and mucin domain-3), also known as HAVCR2, is a 60 kDa member of the TIM family of immune regulating molecules. TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk region (1, 2). Mature human TIM-3 consists of a 181 amino acid (aa) extracellular domain (ECD), a 21 aa transmembrane segment, and a 78 aa cytoplasmic tail (3). An alternatively spliced isoform is truncated within the mucin-like stalk. Within the ECD, human TIM-3 shares 58% aa sequence identity with mouse and rat TIM-3. TIM-3 is up‑regulated on several populations of activated myeloid cells (macrophage, monocyte, dendritic cell, microglia, mast cell) and T cells (Th1, CD8+, NK, Treg) (3-10). Its binding to Galectin-9 induces a range of immunosuppressive functions which enhance immune tolerance and inhibit anti-tumor immunity (11). TIM-3 ligation attenuates CD8+ and Th1 cell responses (11-13) and promotes the activity of Treg and myeloid derived suppressor cells (8, 11, 13, 14). In addition, dendritic cell-expressed TIM-3 dampens inflammation by enabling the phagocytosis of apoptotic cells and the cross-presentation of apoptotic cell antigens (4). It also binds the alarmin HMGB1, thereby preventing the activation of TLRs in response to released tumor cell DNA (7). TIM-3 interactions with Galectin-9 can alternatively trigger immune stimulatory effects, such as the coactivation of NK cell cytotoxicity (10).
- Sakuishi, K. et al. (2011) Trends Immunol. 32:345.
- Anderson, A.C. (2012) Curr. Opin. Immunol. 24:213.
- Monney, L. et al. (2002) Nature 415:536.
- Nakayama, M. et al. (2009) Blood 113:3821.
- Anderson, A.C. et al. (2007) Science 318:1141.
- Wiener, Z. et al. (2007) J. Invest. Dermatol. 127:906.
- Chiba, S. et al. (2012) Nat. Immunol. 13:832.
- Sanchez-Fueyo, A. et al. (2003) Nat. Immunol. 4:1093.
- Ndhlovu, L.C. et al. (2012) Blood 119:3734.
- Gleason, M.K. et al. (2012) Blood 119:3064.
- Zhu, C. et al. (2005) Nat. Immunol. 6:1245.
- Sakhdari, A. et al. (2012) PLoS ONE 7:e40146.
- Sabatos, C.A. et al. (2003) Nat. Immunol. 4:1102.
- Dardalhon, V. et al. (2010) J. Immunol. 185:1383.
Product Datasheets
Citations for Human TIM-3 PerCP-conjugated Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
4
Citations: Showing 1 - 4
Filter your results:
Filter by:
-
Hydrogen gas activates coenzyme Q10 to restore exhausted CD8+ T cells, especially PD-1+Tim3+terminal CD8+ T cells, leading to better nivolumab outcomes in patients with lung cancer
Authors: J Akagi, H Baba
Oncology Letters, 2020-09-18;20(5):258.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Antiparasitic Treatment Induces an Improved CD8(+) T Cell Response in Chronic Chagasic Patients
Authors: J Mateus, E Pérez-Antó, P Lasso, A Egui, N Roa, B Carrilero, JM González, MC Thomas, CJ Puerta, MC López, A Cuéllar
J. Immunol, 2017-03-03;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Inhibitory Receptor Expression on CD8+ T Cells Is Linked to Functional Responses against Trypanosoma cruzi Antigens in Chronic Chagasic Patients.
Authors: Lasso P, Mateus J, Pavia P, Rosas F, Roa N, Thomas M, Lopez M, Gonzalez J, Puerta C, Cuellar A
J Immunol, 2015-09-18;195(8):3748-58.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
CD127 expression, exhaustion status and antigen specific proliferation predict sustained virologic response to IFN in HCV/HIV co-infected individuals.
Authors: Kared H, Saeed S, Klein M, Shoukry N
PLoS ONE, 2014-07-09;9(7):e101441.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human TIM-3 PerCP-conjugated Antibody
There are currently no reviews for this product. Be the first to review Human TIM-3 PerCP-conjugated Antibody and earn rewards!
Have you used Human TIM-3 PerCP-conjugated Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image